Hygieia adds to leadership team with newly created sales VP position | Hygieia

Hygieia adds to leadership team with newly created sales VP position

Increased sales expected for company’s AI-driven d-Nav® technology, which makes insulin therapy safe and effective for people with type 2 diabetes.

Livonia, Michigan, May 18, 2021Hygieia, a digital health company for insulin therapy management, has appointed William Pruitt to the new position of vice president of sales. William joins Hygieia as it embarks on an aggressive growth strategy that includes clinical expansion and partnerships with endocrinologists and primary care physicians throughout Michigan and the United States. 

“William brings extensive leadership experience in developing and implementing winning sales strategies in the healthcare category,” said Mary Ann Tournoux, chief commercial officer at Hygieia. “A type 2 diabetes epidemic is driving demand for our d-Nav insulin management program and William will be instrumental in directing a growing sales team dedicated to Hygieia’s continued expansion.”

He joins Hygieia from Solis Mammography, a national leader in mammography and imaging services, where he served as vice president of sales. Prior to that, William was senior director of sales at Daiichi Sankyo, a global pharmaceutical company. 

“We are excited to be at the forefront of advancing digital health for patients with type 2 diabetes who require insulin,” said William. “We want every healthcare provider treating these patients to experience the value of changing their standard of care for insulin therapy and know that Hygieia’s AI-driven d-Nav technology is how we get there.”

The d-Nav insulin management program uses AI-powered technology to automate insulin dose adjustment. It is the first FDA-cleared technology to adjust a medication dose directly to the patient, acting as a surrogate for a physician and giving users real-time recommendations.

About Hygieia/ d-Nav Insulin Management Program  

Hygieia is a specialty provider of insulin therapy and maker of the d-Nav® Insulin Management Program. The d-Nav program includes an AI-powered application that helps people with type 2 diabetes use insulin in a safe and effective way to control their blood sugar levels. Studies show that some 90 percent of people using d-Nav achieve lower A1c within three months. The d-Nav Insulin Management Program was developed by two University of Michigan researchers and has been peer-reviewed with studies published in leading medical journals. Hygieia is headquartered in Livonia, Michigan. Learn more at hygieia.com.  

Media Contact: Debbie Reinheimer, debbie@reinheimerpr.com, 248-227-3667